nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—CYP2D6—Alzheimer's disease	0.265	1	CbGaD
Almotriptan—CYP2D6—Rivastigmine—Alzheimer's disease	0.0823	0.213	CbGbCtD
Almotriptan—CYP2C19—Memantine—Alzheimer's disease	0.075	0.194	CbGbCtD
Almotriptan—CYP2D6—Donepezil—Alzheimer's disease	0.0658	0.17	CbGbCtD
Almotriptan—CYP3A4—Rivastigmine—Alzheimer's disease	0.0523	0.135	CbGbCtD
Almotriptan—CYP2D6—Galantamine—Alzheimer's disease	0.0424	0.11	CbGbCtD
Almotriptan—CYP3A4—Donepezil—Alzheimer's disease	0.0418	0.108	CbGbCtD
Almotriptan—CYP3A4—Galantamine—Alzheimer's disease	0.0269	0.0697	CbGbCtD
Almotriptan—MAOA—locus ceruleus—Alzheimer's disease	0.00793	0.174	CbGeAlD
Almotriptan—HTR1B—telencephalic ventricle—Alzheimer's disease	0.0051	0.112	CbGeAlD
Almotriptan—HTR1D—telencephalic ventricle—Alzheimer's disease	0.00494	0.108	CbGeAlD
Almotriptan—HTR1B—blood vessel—Alzheimer's disease	0.00253	0.0554	CbGeAlD
Almotriptan—HTR1D—blood vessel—Alzheimer's disease	0.00245	0.0536	CbGeAlD
Almotriptan—Melatonin—MT3—Alzheimer's disease	0.00218	0.443	CrCbGaD
Almotriptan—HTR1B—forebrain—Alzheimer's disease	0.00133	0.0292	CbGeAlD
Almotriptan—HTR1D—forebrain—Alzheimer's disease	0.00129	0.0283	CbGeAlD
Almotriptan—FMO3—nervous system—Alzheimer's disease	0.00123	0.027	CbGeAlD
Almotriptan—HTR1B—telencephalon—Alzheimer's disease	0.00123	0.0269	CbGeAlD
Almotriptan—FMO3—central nervous system—Alzheimer's disease	0.00119	0.026	CbGeAlD
Almotriptan—HTR1D—telencephalon—Alzheimer's disease	0.00119	0.026	CbGeAlD
Almotriptan—MAOA—embryo—Alzheimer's disease	0.00111	0.0244	CbGeAlD
Almotriptan—Melatonin—CALM1—Alzheimer's disease	0.00104	0.211	CrCbGaD
Almotriptan—MAOA—forebrain—Alzheimer's disease	0.000982	0.0215	CbGeAlD
Almotriptan—FMO3—brain—Alzheimer's disease	0.000942	0.0207	CbGeAlD
Almotriptan—MAOA—telencephalon—Alzheimer's disease	0.000903	0.0198	CbGeAlD
Almotriptan—HTR1B—nervous system—Alzheimer's disease	0.000723	0.0159	CbGeAlD
Almotriptan—HTR1D—nervous system—Alzheimer's disease	0.0007	0.0154	CbGeAlD
Almotriptan—HTR1B—central nervous system—Alzheimer's disease	0.000697	0.0153	CbGeAlD
Almotriptan—CYP2E1—telencephalon—Alzheimer's disease	0.000678	0.0149	CbGeAlD
Almotriptan—HTR1D—central nervous system—Alzheimer's disease	0.000674	0.0148	CbGeAlD
Almotriptan—CYP2D6—forebrain—Alzheimer's disease	0.000584	0.0128	CbGeAlD
Almotriptan—Hyperglycaemia—Donepezil—Alzheimer's disease	0.000581	0.00285	CcSEcCtD
Almotriptan—Sweating increased—Memantine—Alzheimer's disease	0.00057	0.00279	CcSEcCtD
Almotriptan—Angina pectoris—Memantine—Alzheimer's disease	0.00057	0.00279	CcSEcCtD
Almotriptan—Tension—Galantamine—Alzheimer's disease	0.000568	0.00278	CcSEcCtD
Almotriptan—Dysgeusia—Galantamine—Alzheimer's disease	0.000567	0.00278	CcSEcCtD
Almotriptan—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000566	0.00277	CcSEcCtD
Almotriptan—Melatonin—MPO—Alzheimer's disease	0.000566	0.115	CrCbGaD
Almotriptan—Myocardial infarction—Donepezil—Alzheimer's disease	0.000563	0.00276	CcSEcCtD
Almotriptan—Nervousness—Galantamine—Alzheimer's disease	0.000563	0.00275	CcSEcCtD
Almotriptan—Bronchitis—Memantine—Alzheimer's disease	0.000563	0.00275	CcSEcCtD
Almotriptan—Back pain—Galantamine—Alzheimer's disease	0.00056	0.00274	CcSEcCtD
Almotriptan—Conjunctivitis—Donepezil—Alzheimer's disease	0.000558	0.00273	CcSEcCtD
Almotriptan—Sweating increased—Rivastigmine—Alzheimer's disease	0.000557	0.00273	CcSEcCtD
Almotriptan—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000557	0.00273	CcSEcCtD
Almotriptan—HTR1B—brain—Alzheimer's disease	0.000553	0.0121	CbGeAlD
Almotriptan—Bronchitis—Rivastigmine—Alzheimer's disease	0.00055	0.00269	CcSEcCtD
Almotriptan—Vision blurred—Galantamine—Alzheimer's disease	0.000546	0.00267	CcSEcCtD
Almotriptan—Tremor—Galantamine—Alzheimer's disease	0.000543	0.00266	CcSEcCtD
Almotriptan—Epistaxis—Donepezil—Alzheimer's disease	0.000542	0.00265	CcSEcCtD
Almotriptan—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000537	0.00263	CcSEcCtD
Almotriptan—CYP2D6—telencephalon—Alzheimer's disease	0.000537	0.0118	CbGeAlD
Almotriptan—HTR1D—brain—Alzheimer's disease	0.000535	0.0117	CbGeAlD
Almotriptan—MAOA—nervous system—Alzheimer's disease	0.000533	0.0117	CbGeAlD
Almotriptan—Agitation—Galantamine—Alzheimer's disease	0.000532	0.00261	CcSEcCtD
Almotriptan—Hyperglycaemia—Memantine—Alzheimer's disease	0.000528	0.00258	CcSEcCtD
Almotriptan—Malaise—Galantamine—Alzheimer's disease	0.000522	0.00256	CcSEcCtD
Almotriptan—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000522	0.00256	CcSEcCtD
Almotriptan—Vertigo—Galantamine—Alzheimer's disease	0.00052	0.00255	CcSEcCtD
Almotriptan—Syncope—Galantamine—Alzheimer's disease	0.000519	0.00254	CcSEcCtD
Almotriptan—Rhinitis—Donepezil—Alzheimer's disease	0.000517	0.00253	CcSEcCtD
Almotriptan—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000516	0.00253	CcSEcCtD
Almotriptan—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000514	0.00252	CcSEcCtD
Almotriptan—MAOA—central nervous system—Alzheimer's disease	0.000513	0.0113	CbGeAlD
Almotriptan—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000513	0.00251	CcSEcCtD
Almotriptan—Palpitations—Galantamine—Alzheimer's disease	0.000512	0.00251	CcSEcCtD
Almotriptan—Pharyngitis—Donepezil—Alzheimer's disease	0.000512	0.00251	CcSEcCtD
Almotriptan—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000511	0.0025	CcSEcCtD
Almotriptan—Myocardial infarction—Memantine—Alzheimer's disease	0.000511	0.0025	CcSEcCtD
Almotriptan—Loss of consciousness—Galantamine—Alzheimer's disease	0.000509	0.00249	CcSEcCtD
Almotriptan—Conjunctivitis—Memantine—Alzheimer's disease	0.000507	0.00248	CcSEcCtD
Almotriptan—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000503	0.00246	CcSEcCtD
Almotriptan—MAOA—cerebellum—Alzheimer's disease	0.000502	0.011	CbGeAlD
Almotriptan—Convulsion—Galantamine—Alzheimer's disease	0.000502	0.00246	CcSEcCtD
Almotriptan—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.0005	0.00245	CcSEcCtD
Almotriptan—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.0005	0.00245	CcSEcCtD
Almotriptan—Hypertension—Galantamine—Alzheimer's disease	0.0005	0.00245	CcSEcCtD
Almotriptan—Visual impairment—Donepezil—Alzheimer's disease	0.000497	0.00243	CcSEcCtD
Almotriptan—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000496	0.00243	CcSEcCtD
Almotriptan—Arthralgia—Galantamine—Alzheimer's disease	0.000493	0.00241	CcSEcCtD
Almotriptan—Myalgia—Galantamine—Alzheimer's disease	0.000493	0.00241	CcSEcCtD
Almotriptan—Chest pain—Galantamine—Alzheimer's disease	0.000493	0.00241	CcSEcCtD
Almotriptan—Epistaxis—Memantine—Alzheimer's disease	0.000492	0.00241	CcSEcCtD
Almotriptan—Anxiety—Galantamine—Alzheimer's disease	0.000491	0.00241	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00049	0.0024	CcSEcCtD
Almotriptan—Sinusitis—Memantine—Alzheimer's disease	0.000489	0.0024	CcSEcCtD
Almotriptan—Discomfort—Galantamine—Alzheimer's disease	0.000487	0.00239	CcSEcCtD
Almotriptan—Dry mouth—Galantamine—Alzheimer's disease	0.000482	0.00236	CcSEcCtD
Almotriptan—Epistaxis—Rivastigmine—Alzheimer's disease	0.000481	0.00236	CcSEcCtD
Almotriptan—Tinnitus—Donepezil—Alzheimer's disease	0.000481	0.00235	CcSEcCtD
Almotriptan—Sinusitis—Rivastigmine—Alzheimer's disease	0.000479	0.00234	CcSEcCtD
Almotriptan—Confusional state—Galantamine—Alzheimer's disease	0.000477	0.00233	CcSEcCtD
Almotriptan—Rhinitis—Memantine—Alzheimer's disease	0.000469	0.0023	CcSEcCtD
Almotriptan—Hypoaesthesia—Memantine—Alzheimer's disease	0.000466	0.00228	CcSEcCtD
Almotriptan—Shock—Galantamine—Alzheimer's disease	0.000465	0.00228	CcSEcCtD
Almotriptan—Pharyngitis—Memantine—Alzheimer's disease	0.000465	0.00228	CcSEcCtD
Almotriptan—Nervous system disorder—Galantamine—Alzheimer's disease	0.000464	0.00227	CcSEcCtD
Almotriptan—Chills—Donepezil—Alzheimer's disease	0.000463	0.00227	CcSEcCtD
Almotriptan—Tachycardia—Galantamine—Alzheimer's disease	0.000461	0.00226	CcSEcCtD
Almotriptan—Rhinitis—Rivastigmine—Alzheimer's disease	0.000459	0.00225	CcSEcCtD
Almotriptan—Skin disorder—Galantamine—Alzheimer's disease	0.000459	0.00225	CcSEcCtD
Almotriptan—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000457	0.00224	CcSEcCtD
Almotriptan—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000456	0.00223	CcSEcCtD
Almotriptan—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000455	0.00223	CcSEcCtD
Almotriptan—Mental disorder—Donepezil—Alzheimer's disease	0.000452	0.00221	CcSEcCtD
Almotriptan—Visual impairment—Memantine—Alzheimer's disease	0.000451	0.00221	CcSEcCtD
Almotriptan—Erythema—Donepezil—Alzheimer's disease	0.000449	0.0022	CcSEcCtD
Almotriptan—Visual impairment—Rivastigmine—Alzheimer's disease	0.000441	0.00216	CcSEcCtD
Almotriptan—Tension—Donepezil—Alzheimer's disease	0.00044	0.00216	CcSEcCtD
Almotriptan—Dysgeusia—Donepezil—Alzheimer's disease	0.00044	0.00215	CcSEcCtD
Almotriptan—Eye disorder—Memantine—Alzheimer's disease	0.000438	0.00214	CcSEcCtD
Almotriptan—Tinnitus—Memantine—Alzheimer's disease	0.000437	0.00214	CcSEcCtD
Almotriptan—Nervousness—Donepezil—Alzheimer's disease	0.000436	0.00213	CcSEcCtD
Almotriptan—Cardiac disorder—Memantine—Alzheimer's disease	0.000434	0.00213	CcSEcCtD
Almotriptan—Back pain—Donepezil—Alzheimer's disease	0.000434	0.00213	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000431	0.00211	CcSEcCtD
Almotriptan—Eletriptan—PTGS1—Alzheimer's disease	0.000428	0.0867	CrCbGaD
Almotriptan—Eye disorder—Rivastigmine—Alzheimer's disease	0.000428	0.0021	CcSEcCtD
Almotriptan—Insomnia—Galantamine—Alzheimer's disease	0.000428	0.00209	CcSEcCtD
Almotriptan—Tinnitus—Rivastigmine—Alzheimer's disease	0.000427	0.00209	CcSEcCtD
Almotriptan—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000425	0.00208	CcSEcCtD
Almotriptan—Melatonin—ESR1—Alzheimer's disease	0.000425	0.086	CrCbGaD
Almotriptan—Paraesthesia—Galantamine—Alzheimer's disease	0.000424	0.00208	CcSEcCtD
Almotriptan—Vision blurred—Donepezil—Alzheimer's disease	0.000423	0.00207	CcSEcCtD
Almotriptan—Immune system disorder—Memantine—Alzheimer's disease	0.000423	0.00207	CcSEcCtD
Almotriptan—Tremor—Donepezil—Alzheimer's disease	0.000421	0.00206	CcSEcCtD
Almotriptan—Somnolence—Galantamine—Alzheimer's disease	0.00042	0.00206	CcSEcCtD
Almotriptan—Chills—Memantine—Alzheimer's disease	0.00042	0.00206	CcSEcCtD
Almotriptan—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000416	0.00204	CcSEcCtD
Almotriptan—Dyspepsia—Galantamine—Alzheimer's disease	0.000416	0.00204	CcSEcCtD
Almotriptan—Agitation—Donepezil—Alzheimer's disease	0.000412	0.00202	CcSEcCtD
Almotriptan—Chills—Rivastigmine—Alzheimer's disease	0.000411	0.00201	CcSEcCtD
Almotriptan—Mental disorder—Memantine—Alzheimer's disease	0.00041	0.00201	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000408	0.002	CcSEcCtD
Almotriptan—MAOA—brain—Alzheimer's disease	0.000408	0.00894	CbGeAlD
Almotriptan—Fatigue—Galantamine—Alzheimer's disease	0.000408	0.002	CcSEcCtD
Almotriptan—Malaise—Donepezil—Alzheimer's disease	0.000405	0.00198	CcSEcCtD
Almotriptan—Vertigo—Donepezil—Alzheimer's disease	0.000403	0.00197	CcSEcCtD
Almotriptan—Syncope—Donepezil—Alzheimer's disease	0.000403	0.00197	CcSEcCtD
Almotriptan—Mental disorder—Rivastigmine—Alzheimer's disease	0.000401	0.00197	CcSEcCtD
Almotriptan—CYP2E1—nervous system—Alzheimer's disease	0.0004	0.00878	CbGeAlD
Almotriptan—Tension—Memantine—Alzheimer's disease	0.0004	0.00196	CcSEcCtD
Almotriptan—Dysgeusia—Memantine—Alzheimer's disease	0.000399	0.00195	CcSEcCtD
Almotriptan—Erythema—Rivastigmine—Alzheimer's disease	0.000399	0.00195	CcSEcCtD
Almotriptan—Nervousness—Memantine—Alzheimer's disease	0.000396	0.00194	CcSEcCtD
Almotriptan—Loss of consciousness—Donepezil—Alzheimer's disease	0.000395	0.00193	CcSEcCtD
Almotriptan—Back pain—Memantine—Alzheimer's disease	0.000394	0.00193	CcSEcCtD
Almotriptan—Tension—Rivastigmine—Alzheimer's disease	0.000391	0.00192	CcSEcCtD
Almotriptan—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00039	0.00191	CcSEcCtD
Almotriptan—Feeling abnormal—Galantamine—Alzheimer's disease	0.00039	0.00191	CcSEcCtD
Almotriptan—Convulsion—Donepezil—Alzheimer's disease	0.000389	0.0019	CcSEcCtD
Almotriptan—Hypertension—Donepezil—Alzheimer's disease	0.000388	0.0019	CcSEcCtD
Almotriptan—Nervousness—Rivastigmine—Alzheimer's disease	0.000387	0.0019	CcSEcCtD
Almotriptan—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000387	0.00189	CcSEcCtD
Almotriptan—Back pain—Rivastigmine—Alzheimer's disease	0.000386	0.00189	CcSEcCtD
Almotriptan—CYP2E1—central nervous system—Alzheimer's disease	0.000385	0.00845	CbGeAlD
Almotriptan—Vision blurred—Memantine—Alzheimer's disease	0.000384	0.00188	CcSEcCtD
Almotriptan—Arthralgia—Donepezil—Alzheimer's disease	0.000382	0.00187	CcSEcCtD
Almotriptan—Chest pain—Donepezil—Alzheimer's disease	0.000382	0.00187	CcSEcCtD
Almotriptan—Myalgia—Donepezil—Alzheimer's disease	0.000382	0.00187	CcSEcCtD
Almotriptan—Tremor—Memantine—Alzheimer's disease	0.000382	0.00187	CcSEcCtD
Almotriptan—Anxiety—Donepezil—Alzheimer's disease	0.000381	0.00186	CcSEcCtD
Almotriptan—Ill-defined disorder—Memantine—Alzheimer's disease	0.000378	0.00185	CcSEcCtD
Almotriptan—Discomfort—Donepezil—Alzheimer's disease	0.000378	0.00185	CcSEcCtD
Almotriptan—CYP2E1—cerebellum—Alzheimer's disease	0.000377	0.00826	CbGeAlD
Almotriptan—Vision blurred—Rivastigmine—Alzheimer's disease	0.000376	0.00184	CcSEcCtD
Almotriptan—Agitation—Memantine—Alzheimer's disease	0.000375	0.00183	CcSEcCtD
Almotriptan—Dry mouth—Donepezil—Alzheimer's disease	0.000374	0.00183	CcSEcCtD
Almotriptan—Abdominal pain—Galantamine—Alzheimer's disease	0.000374	0.00183	CcSEcCtD
Almotriptan—Body temperature increased—Galantamine—Alzheimer's disease	0.000374	0.00183	CcSEcCtD
Almotriptan—Tremor—Rivastigmine—Alzheimer's disease	0.000374	0.00183	CcSEcCtD
Almotriptan—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00037	0.00181	CcSEcCtD
Almotriptan—Confusional state—Donepezil—Alzheimer's disease	0.000369	0.00181	CcSEcCtD
Almotriptan—Malaise—Memantine—Alzheimer's disease	0.000368	0.0018	CcSEcCtD
Almotriptan—Agitation—Rivastigmine—Alzheimer's disease	0.000366	0.00179	CcSEcCtD
Almotriptan—Vertigo—Memantine—Alzheimer's disease	0.000366	0.00179	CcSEcCtD
Almotriptan—Syncope—Memantine—Alzheimer's disease	0.000365	0.00179	CcSEcCtD
Almotriptan—CYP2C8—brain—Alzheimer's disease	0.000363	0.00797	CbGeAlD
Almotriptan—Shock—Donepezil—Alzheimer's disease	0.00036	0.00176	CcSEcCtD
Almotriptan—Palpitations—Memantine—Alzheimer's disease	0.00036	0.00176	CcSEcCtD
Almotriptan—Malaise—Rivastigmine—Alzheimer's disease	0.00036	0.00176	CcSEcCtD
Almotriptan—Nervous system disorder—Donepezil—Alzheimer's disease	0.000359	0.00176	CcSEcCtD
Almotriptan—Vertigo—Rivastigmine—Alzheimer's disease	0.000358	0.00175	CcSEcCtD
Almotriptan—Loss of consciousness—Memantine—Alzheimer's disease	0.000358	0.00175	CcSEcCtD
Almotriptan—Syncope—Rivastigmine—Alzheimer's disease	0.000358	0.00175	CcSEcCtD
Almotriptan—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000354	0.00173	CcSEcCtD
Almotriptan—Convulsion—Memantine—Alzheimer's disease	0.000353	0.00173	CcSEcCtD
Almotriptan—Palpitations—Rivastigmine—Alzheimer's disease	0.000352	0.00173	CcSEcCtD
Almotriptan—Hypertension—Memantine—Alzheimer's disease	0.000352	0.00172	CcSEcCtD
Almotriptan—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00035	0.00172	CcSEcCtD
Almotriptan—Hypersensitivity—Galantamine—Alzheimer's disease	0.000348	0.00171	CcSEcCtD
Almotriptan—Arthralgia—Memantine—Alzheimer's disease	0.000347	0.0017	CcSEcCtD
Almotriptan—Chest pain—Memantine—Alzheimer's disease	0.000347	0.0017	CcSEcCtD
Almotriptan—Myalgia—Memantine—Alzheimer's disease	0.000347	0.0017	CcSEcCtD
Almotriptan—Anxiety—Memantine—Alzheimer's disease	0.000346	0.00169	CcSEcCtD
Almotriptan—Convulsion—Rivastigmine—Alzheimer's disease	0.000345	0.00169	CcSEcCtD
Almotriptan—Hypertension—Rivastigmine—Alzheimer's disease	0.000344	0.00169	CcSEcCtD
Almotriptan—Discomfort—Memantine—Alzheimer's disease	0.000343	0.00168	CcSEcCtD
Almotriptan—Arthralgia—Rivastigmine—Alzheimer's disease	0.000339	0.00166	CcSEcCtD
Almotriptan—Chest pain—Rivastigmine—Alzheimer's disease	0.000339	0.00166	CcSEcCtD
Almotriptan—Myalgia—Rivastigmine—Alzheimer's disease	0.000339	0.00166	CcSEcCtD
Almotriptan—Dry mouth—Memantine—Alzheimer's disease	0.000339	0.00166	CcSEcCtD
Almotriptan—Asthenia—Galantamine—Alzheimer's disease	0.000339	0.00166	CcSEcCtD
Almotriptan—Anxiety—Rivastigmine—Alzheimer's disease	0.000338	0.00166	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000337	0.00165	CcSEcCtD
Almotriptan—Confusional state—Memantine—Alzheimer's disease	0.000335	0.00164	CcSEcCtD
Almotriptan—Discomfort—Rivastigmine—Alzheimer's disease	0.000335	0.00164	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000334	0.00163	CcSEcCtD
Almotriptan—Dry mouth—Rivastigmine—Alzheimer's disease	0.000332	0.00163	CcSEcCtD
Almotriptan—Insomnia—Donepezil—Alzheimer's disease	0.000331	0.00162	CcSEcCtD
Almotriptan—Paraesthesia—Donepezil—Alzheimer's disease	0.000329	0.00161	CcSEcCtD
Almotriptan—Confusional state—Rivastigmine—Alzheimer's disease	0.000328	0.00161	CcSEcCtD
Almotriptan—Shock—Memantine—Alzheimer's disease	0.000327	0.0016	CcSEcCtD
Almotriptan—Dyspnoea—Donepezil—Alzheimer's disease	0.000327	0.0016	CcSEcCtD
Almotriptan—Nervous system disorder—Memantine—Alzheimer's disease	0.000326	0.0016	CcSEcCtD
Almotriptan—Somnolence—Donepezil—Alzheimer's disease	0.000326	0.00159	CcSEcCtD
Almotriptan—Tachycardia—Memantine—Alzheimer's disease	0.000325	0.00159	CcSEcCtD
Almotriptan—Diarrhoea—Galantamine—Alzheimer's disease	0.000323	0.00158	CcSEcCtD
Almotriptan—Skin disorder—Memantine—Alzheimer's disease	0.000323	0.00158	CcSEcCtD
Almotriptan—Dyspepsia—Donepezil—Alzheimer's disease	0.000322	0.00158	CcSEcCtD
Almotriptan—CYP3A4—nervous system—Alzheimer's disease	0.000322	0.00706	CbGeAlD
Almotriptan—Hyperhidrosis—Memantine—Alzheimer's disease	0.000322	0.00157	CcSEcCtD
Almotriptan—Shock—Rivastigmine—Alzheimer's disease	0.00032	0.00157	CcSEcCtD
Almotriptan—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000319	0.00156	CcSEcCtD
Almotriptan—Tachycardia—Rivastigmine—Alzheimer's disease	0.000318	0.00156	CcSEcCtD
Almotriptan—CYP2D6—nervous system—Alzheimer's disease	0.000317	0.00695	CbGeAlD
Almotriptan—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000316	0.00155	CcSEcCtD
Almotriptan—Skin disorder—Rivastigmine—Alzheimer's disease	0.000316	0.00155	CcSEcCtD
Almotriptan—Fatigue—Donepezil—Alzheimer's disease	0.000316	0.00155	CcSEcCtD
Almotriptan—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000315	0.00154	CcSEcCtD
Almotriptan—Pain—Donepezil—Alzheimer's disease	0.000313	0.00153	CcSEcCtD
Almotriptan—Dizziness—Galantamine—Alzheimer's disease	0.000313	0.00153	CcSEcCtD
Almotriptan—CYP3A4—central nervous system—Alzheimer's disease	0.00031	0.0068	CbGeAlD
Almotriptan—CYP2E1—brain—Alzheimer's disease	0.000306	0.00671	CbGeAlD
Almotriptan—CYP2D6—central nervous system—Alzheimer's disease	0.000305	0.00669	CbGeAlD
Almotriptan—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000303	0.00148	CcSEcCtD
Almotriptan—Feeling abnormal—Donepezil—Alzheimer's disease	0.000302	0.00148	CcSEcCtD
Almotriptan—Insomnia—Memantine—Alzheimer's disease	0.000301	0.00147	CcSEcCtD
Almotriptan—Vomiting—Galantamine—Alzheimer's disease	0.000301	0.00147	CcSEcCtD
Almotriptan—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.0003	0.00147	CcSEcCtD
Almotriptan—Paraesthesia—Memantine—Alzheimer's disease	0.000299	0.00146	CcSEcCtD
Almotriptan—CYP2D6—cerebellum—Alzheimer's disease	0.000298	0.00654	CbGeAlD
Almotriptan—Rash—Galantamine—Alzheimer's disease	0.000298	0.00146	CcSEcCtD
Almotriptan—Dermatitis—Galantamine—Alzheimer's disease	0.000298	0.00146	CcSEcCtD
Almotriptan—Dyspnoea—Memantine—Alzheimer's disease	0.000297	0.00145	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000296	0.00145	CcSEcCtD
Almotriptan—Headache—Galantamine—Alzheimer's disease	0.000296	0.00145	CcSEcCtD
Almotriptan—Somnolence—Memantine—Alzheimer's disease	0.000296	0.00145	CcSEcCtD
Almotriptan—Insomnia—Rivastigmine—Alzheimer's disease	0.000294	0.00144	CcSEcCtD
Almotriptan—Dyspepsia—Memantine—Alzheimer's disease	0.000293	0.00143	CcSEcCtD
Almotriptan—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000292	0.00143	CcSEcCtD
Almotriptan—Eletriptan—CYP2D6—Alzheimer's disease	0.000291	0.059	CrCbGaD
Almotriptan—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00029	0.00142	CcSEcCtD
Almotriptan—Abdominal pain—Donepezil—Alzheimer's disease	0.00029	0.00142	CcSEcCtD
Almotriptan—Body temperature increased—Donepezil—Alzheimer's disease	0.00029	0.00142	CcSEcCtD
Almotriptan—Somnolence—Rivastigmine—Alzheimer's disease	0.000289	0.00142	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000287	0.00141	CcSEcCtD
Almotriptan—Fatigue—Memantine—Alzheimer's disease	0.000287	0.0014	CcSEcCtD
Almotriptan—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000286	0.0014	CcSEcCtD
Almotriptan—Pain—Memantine—Alzheimer's disease	0.000284	0.00139	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000281	0.00138	CcSEcCtD
Almotriptan—Nausea—Galantamine—Alzheimer's disease	0.000281	0.00137	CcSEcCtD
Almotriptan—Fatigue—Rivastigmine—Alzheimer's disease	0.000281	0.00137	CcSEcCtD
Almotriptan—Pain—Rivastigmine—Alzheimer's disease	0.000278	0.00136	CcSEcCtD
Almotriptan—Feeling abnormal—Memantine—Alzheimer's disease	0.000274	0.00134	CcSEcCtD
Almotriptan—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000272	0.00133	CcSEcCtD
Almotriptan—Hypersensitivity—Donepezil—Alzheimer's disease	0.00027	0.00132	CcSEcCtD
Almotriptan—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000268	0.00131	CcSEcCtD
Almotriptan—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000266	0.0013	CcSEcCtD
Almotriptan—Abdominal pain—Memantine—Alzheimer's disease	0.000263	0.00129	CcSEcCtD
Almotriptan—Body temperature increased—Memantine—Alzheimer's disease	0.000263	0.00129	CcSEcCtD
Almotriptan—Asthenia—Donepezil—Alzheimer's disease	0.000263	0.00129	CcSEcCtD
Almotriptan—Pruritus—Donepezil—Alzheimer's disease	0.000259	0.00127	CcSEcCtD
Almotriptan—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000257	0.00126	CcSEcCtD
Almotriptan—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000257	0.00126	CcSEcCtD
Almotriptan—Diarrhoea—Donepezil—Alzheimer's disease	0.000251	0.00123	CcSEcCtD
Almotriptan—Hypersensitivity—Memantine—Alzheimer's disease	0.000245	0.0012	CcSEcCtD
Almotriptan—CYP2D6—brain—Alzheimer's disease	0.000242	0.00531	CbGeAlD
Almotriptan—Dizziness—Donepezil—Alzheimer's disease	0.000242	0.00119	CcSEcCtD
Almotriptan—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00024	0.00117	CcSEcCtD
Almotriptan—Asthenia—Memantine—Alzheimer's disease	0.000239	0.00117	CcSEcCtD
Almotriptan—Pruritus—Memantine—Alzheimer's disease	0.000235	0.00115	CcSEcCtD
Almotriptan—Asthenia—Rivastigmine—Alzheimer's disease	0.000233	0.00114	CcSEcCtD
Almotriptan—Vomiting—Donepezil—Alzheimer's disease	0.000233	0.00114	CcSEcCtD
Almotriptan—Rash—Donepezil—Alzheimer's disease	0.000231	0.00113	CcSEcCtD
Almotriptan—Dermatitis—Donepezil—Alzheimer's disease	0.000231	0.00113	CcSEcCtD
Almotriptan—Pruritus—Rivastigmine—Alzheimer's disease	0.00023	0.00113	CcSEcCtD
Almotriptan—Headache—Donepezil—Alzheimer's disease	0.000229	0.00112	CcSEcCtD
Almotriptan—Diarrhoea—Memantine—Alzheimer's disease	0.000228	0.00111	CcSEcCtD
Almotriptan—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000223	0.00109	CcSEcCtD
Almotriptan—Dizziness—Memantine—Alzheimer's disease	0.00022	0.00108	CcSEcCtD
Almotriptan—Nausea—Donepezil—Alzheimer's disease	0.000218	0.00107	CcSEcCtD
Almotriptan—Dizziness—Rivastigmine—Alzheimer's disease	0.000215	0.00105	CcSEcCtD
Almotriptan—Vomiting—Memantine—Alzheimer's disease	0.000211	0.00104	CcSEcCtD
Almotriptan—Rash—Memantine—Alzheimer's disease	0.00021	0.00103	CcSEcCtD
Almotriptan—Dermatitis—Memantine—Alzheimer's disease	0.00021	0.00103	CcSEcCtD
Almotriptan—Headache—Memantine—Alzheimer's disease	0.000208	0.00102	CcSEcCtD
Almotriptan—Vomiting—Rivastigmine—Alzheimer's disease	0.000207	0.00101	CcSEcCtD
Almotriptan—Rash—Rivastigmine—Alzheimer's disease	0.000205	0.001	CcSEcCtD
Almotriptan—Dermatitis—Rivastigmine—Alzheimer's disease	0.000205	0.001	CcSEcCtD
Almotriptan—Headache—Rivastigmine—Alzheimer's disease	0.000204	0.000998	CcSEcCtD
Almotriptan—Nausea—Memantine—Alzheimer's disease	0.000198	0.000968	CcSEcCtD
Almotriptan—Nausea—Rivastigmine—Alzheimer's disease	0.000193	0.000947	CcSEcCtD
Almotriptan—HTR1B—Signaling Pathways—NGFR—Alzheimer's disease	1.53e-05	0.000164	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ADAM10—Alzheimer's disease	1.53e-05	0.000164	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CREB1—Alzheimer's disease	1.52e-05	0.000163	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CCL2—Alzheimer's disease	1.52e-05	0.000163	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.51e-05	0.000162	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—A2M—Alzheimer's disease	1.51e-05	0.000162	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ADAM10—Alzheimer's disease	1.5e-05	0.00016	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CCL2—Alzheimer's disease	1.49e-05	0.00016	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PPARGC1A—Alzheimer's disease	1.47e-05	0.000157	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—TPI1—Alzheimer's disease	1.46e-05	0.000157	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CHAT—Alzheimer's disease	1.46e-05	0.000157	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—HMOX1—Alzheimer's disease	1.46e-05	0.000157	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—S100B—Alzheimer's disease	1.44e-05	0.000155	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.43e-05	0.000154	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.42e-05	0.000152	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—S100B—Alzheimer's disease	1.41e-05	0.000152	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.41e-05	0.000151	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—MAOB—Alzheimer's disease	1.4e-05	0.00015	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IGF2—Alzheimer's disease	1.38e-05	0.000147	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.37e-05	0.000147	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GAPDH—Alzheimer's disease	1.35e-05	0.000145	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IGF2—Alzheimer's disease	1.35e-05	0.000144	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—LPL—Alzheimer's disease	1.34e-05	0.000143	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.34e-05	0.000143	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IGF1R—Alzheimer's disease	1.33e-05	0.000143	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.32e-05	0.000142	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ACHE—Alzheimer's disease	1.31e-05	0.000141	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.31e-05	0.000141	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—TPI1—Alzheimer's disease	1.31e-05	0.00014	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CHAT—Alzheimer's disease	1.31e-05	0.00014	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—A2M—Alzheimer's disease	1.3e-05	0.00014	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IGF1R—Alzheimer's disease	1.3e-05	0.00014	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—INPP5D—Alzheimer's disease	1.3e-05	0.000139	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—LPL—Alzheimer's disease	1.28e-05	0.000137	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MEF2C—Alzheimer's disease	1.26e-05	0.000135	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.26e-05	0.000135	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—MAOB—Alzheimer's disease	1.25e-05	0.000134	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—LPL—Alzheimer's disease	1.25e-05	0.000134	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PRKCG—Alzheimer's disease	1.24e-05	0.000133	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MEF2C—Alzheimer's disease	1.24e-05	0.000133	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTGS1—Alzheimer's disease	1.23e-05	0.000132	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ENO1—Alzheimer's disease	1.23e-05	0.000132	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.22e-05	0.000131	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.22e-05	0.00013	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PRKCG—Alzheimer's disease	1.21e-05	0.00013	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NGF—Alzheimer's disease	1.21e-05	0.000129	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP2D6—Alzheimer's disease	1.21e-05	0.000129	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	1.21e-05	0.000129	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—MTHFR—Alzheimer's disease	1.2e-05	0.000129	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.2e-05	0.000129	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.2e-05	0.000129	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.19e-05	0.000128	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NGF—Alzheimer's disease	1.18e-05	0.000127	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.18e-05	0.000127	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCR5—Alzheimer's disease	1.17e-05	0.000126	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—A2M—Alzheimer's disease	1.16e-05	0.000125	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.16e-05	0.000125	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—MAOB—Alzheimer's disease	1.15e-05	0.000123	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCR5—Alzheimer's disease	1.15e-05	0.000123	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HTR2A—Alzheimer's disease	1.15e-05	0.000123	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—BCHE—Alzheimer's disease	1.14e-05	0.000123	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ACHE—Alzheimer's disease	1.13e-05	0.000122	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HTR2A—Alzheimer's disease	1.13e-05	0.000121	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CALM1—Alzheimer's disease	1.13e-05	0.000121	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—INPP5D—Alzheimer's disease	1.12e-05	0.00012	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—APOE—Alzheimer's disease	1.12e-05	0.00012	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CAV1—Alzheimer's disease	1.11e-05	0.000119	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	1.11e-05	0.000119	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.11e-05	0.000119	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PLCB1—Alzheimer's disease	1.08e-05	0.000116	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CALM1—Alzheimer's disease	1.07e-05	0.000115	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—A2M—Alzheimer's disease	1.07e-05	0.000115	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—APOE—Alzheimer's disease	1.07e-05	0.000115	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—LEP—Alzheimer's disease	1.07e-05	0.000115	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ENO1—Alzheimer's disease	1.06e-05	0.000114	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTGS1—Alzheimer's disease	1.06e-05	0.000114	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CAV1—Alzheimer's disease	1.06e-05	0.000113	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CALM1—Alzheimer's disease	1.05e-05	0.000113	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—APOE—Alzheimer's disease	1.05e-05	0.000112	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—LEP—Alzheimer's disease	1.05e-05	0.000112	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ABCA1—Alzheimer's disease	1.05e-05	0.000112	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	1.04e-05	0.000112	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.04e-05	0.000111	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CAV1—Alzheimer's disease	1.04e-05	0.000111	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ESR1—Alzheimer's disease	1.02e-05	0.000109	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—TPI1—Alzheimer's disease	1.02e-05	0.000109	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CHAT—Alzheimer's disease	1.02e-05	0.000109	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ACHE—Alzheimer's disease	1.01e-05	0.000109	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—F2—Alzheimer's disease	1.01e-05	0.000108	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	1e-05	0.000107	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ESR1—Alzheimer's disease	9.99e-06	0.000107	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—BCHE—Alzheimer's disease	9.89e-06	0.000106	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—F2—Alzheimer's disease	9.87e-06	0.000106	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NOTCH1—Alzheimer's disease	9.86e-06	0.000106	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PPARG—Alzheimer's disease	9.77e-06	0.000105	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—MAOB—Alzheimer's disease	9.76e-06	0.000105	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NOTCH1—Alzheimer's disease	9.66e-06	0.000103	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—INS—Alzheimer's disease	9.58e-06	0.000103	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ENO1—Alzheimer's disease	9.49e-06	0.000102	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	9.49e-06	0.000102	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	9.39e-06	0.000101	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	9.33e-06	0.0001	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ACHE—Alzheimer's disease	9.32e-06	9.98e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	9.31e-06	9.97e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	9.29e-06	9.95e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—GSK3B—Alzheimer's disease	9.26e-06	9.92e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	9.21e-06	9.87e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	9.2e-06	9.86e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CREB1—Alzheimer's disease	9.18e-06	9.84e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	9.15e-06	9.81e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—INS—Alzheimer's disease	9.13e-06	9.78e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—A2M—Alzheimer's disease	9.07e-06	9.72e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—GSK3B—Alzheimer's disease	9.06e-06	9.71e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	9.04e-06	9.69e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PPARGC1A—Alzheimer's disease	9.02e-06	9.66e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CREB1—Alzheimer's disease	8.99e-06	9.63e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCL2—Alzheimer's disease	8.98e-06	9.63e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—HMOX1—Alzheimer's disease	8.98e-06	9.62e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—INS—Alzheimer's disease	8.94e-06	9.58e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IGF1—Alzheimer's disease	8.83e-06	9.46e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—BCHE—Alzheimer's disease	8.83e-06	9.46e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCL2—Alzheimer's disease	8.8e-06	9.43e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ENO1—Alzheimer's disease	8.73e-06	9.36e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	8.73e-06	9.36e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IGF1—Alzheimer's disease	8.65e-06	9.27e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—NOS3—Alzheimer's disease	8.4e-06	9e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	8.33e-06	8.92e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—LPL—Alzheimer's disease	8.21e-06	8.8e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	8.17e-06	8.75e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—BCHE—Alzheimer's disease	8.12e-06	8.7e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	8.09e-06	8.67e-05	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—AKT1—Alzheimer's disease	8.08e-06	8.66e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	8.07e-06	8.65e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NOS3—Alzheimer's disease	8.01e-06	8.58e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ACHE—Alzheimer's disease	7.89e-06	8.46e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CHAT—Alzheimer's disease	7.86e-06	8.42e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—TPI1—Alzheimer's disease	7.86e-06	8.42e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NOS3—Alzheimer's disease	7.84e-06	8.4e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	7.8e-06	8.36e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	7.79e-06	8.35e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	7.76e-06	8.31e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PTGS2—Alzheimer's disease	7.69e-06	8.23e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	7.66e-06	8.21e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MAOB—Alzheimer's disease	7.53e-06	8.07e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	7.42e-06	7.95e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ENO1—Alzheimer's disease	7.4e-06	7.93e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	7.4e-06	7.93e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—MTHFR—Alzheimer's disease	7.39e-06	7.92e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	7.25e-06	7.77e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	7.25e-06	7.77e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—LPL—Alzheimer's disease	7.1e-06	7.6e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—A2M—Alzheimer's disease	7e-06	7.5e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	6.96e-06	7.45e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	6.93e-06	7.42e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CALM1—Alzheimer's disease	6.91e-06	7.4e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—APOE—Alzheimer's disease	6.88e-06	7.37e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—BCHE—Alzheimer's disease	6.88e-06	7.37e-05	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—AKT1—Alzheimer's disease	6.86e-06	7.35e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CAV1—Alzheimer's disease	6.82e-06	7.31e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CASP3—Alzheimer's disease	6.8e-06	7.28e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL6—Alzheimer's disease	6.75e-06	7.24e-05	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—AKT1—Alzheimer's disease	6.72e-06	7.2e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CASP3—Alzheimer's disease	6.66e-06	7.13e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL6—Alzheimer's disease	6.61e-06	7.09e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	6.49e-06	6.95e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	6.4e-06	6.86e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	6.39e-06	6.85e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	6.37e-06	6.82e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.36e-06	6.82e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—LPL—Alzheimer's disease	6.33e-06	6.79e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	6.29e-06	6.74e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MAPK8—Alzheimer's disease	6.25e-06	6.69e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—AKT1—Alzheimer's disease	6.23e-06	6.68e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MAPK8—Alzheimer's disease	6.12e-06	6.56e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—AKT1—Alzheimer's disease	6.1e-06	6.54e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ACHE—Alzheimer's disease	6.09e-06	6.53e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	6.02e-06	6.45e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PPARG—Alzheimer's disease	5.99e-06	6.42e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CALM1—Alzheimer's disease	5.97e-06	6.4e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—APOE—Alzheimer's disease	5.95e-06	6.37e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CAV1—Alzheimer's disease	5.89e-06	6.31e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—INS—Alzheimer's disease	5.88e-06	6.3e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—LPL—Alzheimer's disease	5.83e-06	6.24e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—VEGFA—Alzheimer's disease	5.77e-06	6.18e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	5.71e-06	6.12e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ENO1—Alzheimer's disease	5.71e-06	6.12e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	5.7e-06	6.11e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—VEGFA—Alzheimer's disease	5.65e-06	6.05e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	5.6e-06	6e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	5.42e-06	5.81e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	5.4e-06	5.78e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CALM1—Alzheimer's disease	5.33e-06	5.71e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—APOE—Alzheimer's disease	5.31e-06	5.69e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—BCHE—Alzheimer's disease	5.31e-06	5.69e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TGFB1—Alzheimer's disease	5.29e-06	5.67e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CAV1—Alzheimer's disease	5.26e-06	5.64e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	5.25e-06	5.62e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TGFB1—Alzheimer's disease	5.18e-06	5.56e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PPARG—Alzheimer's disease	5.18e-06	5.55e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—NOS3—Alzheimer's disease	5.16e-06	5.52e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—INS—Alzheimer's disease	5.08e-06	5.44e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	5.01e-06	5.37e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—LPL—Alzheimer's disease	4.94e-06	5.29e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CALM1—Alzheimer's disease	4.9e-06	5.25e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—APOE—Alzheimer's disease	4.88e-06	5.23e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	4.85e-06	5.2e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CAV1—Alzheimer's disease	4.84e-06	5.18e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	4.72e-06	5.05e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PPARG—Alzheimer's disease	4.62e-06	4.95e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—INS—Alzheimer's disease	4.54e-06	4.86e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—NOS3—Alzheimer's disease	4.46e-06	4.77e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	4.44e-06	4.76e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TP53—Alzheimer's disease	4.36e-06	4.67e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TP53—Alzheimer's disease	4.27e-06	4.57e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PPARG—Alzheimer's disease	4.25e-06	4.56e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	4.18e-06	4.48e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—INS—Alzheimer's disease	4.17e-06	4.47e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	4.16e-06	4.46e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CALM1—Alzheimer's disease	4.15e-06	4.45e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—APOE—Alzheimer's disease	4.14e-06	4.43e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CAV1—Alzheimer's disease	4.1e-06	4.39e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	4.08e-06	4.37e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL6—Alzheimer's disease	3.99e-06	4.28e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—NOS3—Alzheimer's disease	3.98e-06	4.26e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL6—Alzheimer's disease	3.91e-06	4.19e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—AKT1—Alzheimer's disease	3.86e-06	4.14e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.81e-06	4.08e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—AKT1—Alzheimer's disease	3.68e-06	3.94e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NOS3—Alzheimer's disease	3.66e-06	3.92e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	3.64e-06	3.9e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—AKT1—Alzheimer's disease	3.6e-06	3.86e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PPARG—Alzheimer's disease	3.6e-06	3.86e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—INS—Alzheimer's disease	3.53e-06	3.79e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	3.43e-06	3.67e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	3.35e-06	3.59e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CALM1—Alzheimer's disease	3.2e-06	3.43e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—APOE—Alzheimer's disease	3.19e-06	3.42e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CAV1—Alzheimer's disease	3.16e-06	3.39e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NOS3—Alzheimer's disease	3.1e-06	3.32e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	2.83e-06	3.04e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.78e-06	2.98e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—INS—Alzheimer's disease	2.73e-06	2.92e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.39e-06	2.56e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—AKT1—Alzheimer's disease	2.37e-06	2.54e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.19e-06	2.34e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—AKT1—Alzheimer's disease	2.05e-06	2.19e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.83e-06	1.96e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.68e-06	1.8e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AKT1—Alzheimer's disease	1.42e-06	1.53e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.1e-06	1.18e-05	CbGpPWpGaD
